Perrigo Company plc (LON:0Y5E)

Market Cap	2.54B
Revenue (ttm)	3.49B
Net Income (ttm)	-137.23M
Shares Out	n/a
EPS (ttm)	-1.00
PE Ratio	n/a
Forward PE	n/a
Dividend	0.87 (3.42%)
Ex-Dividend Date	Mar 7, 2025

Volume	11
Average Volume	256
Open	25.31
Previous Close	n/a
Day's Range	25.24 - 25.41
52-Week Range	25.24 - 40.01
Beta	0.49
RSI	43.30
Earnings Date	May 9, 2025

About Perrigo Company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain rel...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1887
• Employees: 8,379
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Y5E

Financial Performance

In 2024, Perrigo Company's revenue was $4.37 billion, a decrease of -6.06% compared to the previous year's $4.66 billion. Losses were -$171.80 million, 1252.8% more than in 2023.

Financial numbers in USD